MAGE3 and Survivin activated dendritic cell immunotherapy for the treatment of non-small cell lung cancer.
about
MAGE3 and Survivin activated dendritic cell immunotherapy for the treatment of non-small cell lung cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
MAGE3 and Survivin activated d ...... of non-small cell lung cancer.
@en
MAGE3 and Survivin activated d ...... of non-small cell lung cancer.
@nl
type
label
MAGE3 and Survivin activated d ...... of non-small cell lung cancer.
@en
MAGE3 and Survivin activated d ...... of non-small cell lung cancer.
@nl
prefLabel
MAGE3 and Survivin activated d ...... of non-small cell lung cancer.
@en
MAGE3 and Survivin activated d ...... of non-small cell lung cancer.
@nl
P2860
P356
P1433
P1476
MAGE3 and Survivin activated d ...... of non-small cell lung cancer.
@en
P2860
P304
P356
10.3892/OL.2018.8362
P577
2018-03-28T00:00:00Z